|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/15/13 China Health Inds Holdings, Inc. 10-K 6/30/13 77:8.3M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 948K
2: EX-10.22 Material Contract HTML 49K
3: EX-10.23 Material Contract HTML 32K
4: EX-10.24 Material Contract HTML 32K
5: EX-23.1 Consent of Experts or Counsel HTML 20K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
76: R1 Document And Entity Information HTML 51K
52: R2 Consolidated Balance Sheets HTML 100K
48: R3 Consolidated Balance Sheets [Parenthetical] HTML 31K
18: R4 Consolidated Statements of Operations and HTML 96K
Comprehensive Income
50: R5 Consolidated Statementsof Stockholders' Equity HTML 53K
35: R6 Consolidated Statements of Cash Flows HTML 102K
66: R7 Organization and Business Background HTML 31K
36: R8 Significant Accounting Policies HTML 200K
38: R9 Cash and Cash Equivalents HTML 27K
19: R10 Control by Principal Owners HTML 23K
37: R11 Accounts Receivable HTML 29K
65: R12 Other Receivables HTML 43K
61: R13 Inventory HTML 74K
49: R14 Long Term Deposit HTML 31K
73: R15 Prepaid Expenses HTML 57K
64: R16 Construction in Progress HTML 39K
15: R17 Property, Plant and Equipment HTML 88K
22: R18 Intangible Assets HTML 63K
72: R19 Related Party Debt HTML 32K
75: R20 Income Tax and Taxes Payable HTML 75K
77: R21 Earnings Per Share HTML 49K
74: R22 Commitments and Contingencies HTML 68K
55: R23 Major Suppliers and Customers HTML 40K
20: R24 Subsequent Events HTML 23K
34: R25 Significant Accounting Policies (Policies) HTML 261K
27: R26 Significant Accounting Policies (Tables) HTML 24K
26: R27 Other Receivables (Tables) HTML 37K
40: R28 Inventory (Tables) HTML 71K
54: R29 Prepaid Expenses (Tables) HTML 43K
62: R30 Property, Plant and Equipment (Tables) HTML 80K
32: R31 Intangible Assets (Tables) HTML 58K
41: R32 Income Tax and Taxes Payable (Tables) HTML 76K
70: R33 Earnings Per Share (Tables) HTML 44K
29: R34 Commitments and Contingencies (Tables) HTML 45K
59: R35 Organization and Business Background (Details HTML 42K
Textual)
60: R36 Significant Accounting Policies (Details) HTML 25K
42: R37 Significant Accounting Policies (Details Textual) HTML 108K
25: R38 Cash and Cash Equivalents (Details Textual) HTML 23K
58: R39 Accounts Receivable (Details Textual) HTML 22K
30: R40 Other Receivables (Details) HTML 32K
39: R41 Other Receivables (Details Textual) HTML 52K
63: R42 Inventory (Details) HTML 33K
33: R43 Long Term Deposit (Details Textual) HTML 31K
56: R44 Prepaid Expenses (Details) HTML 29K
47: R45 Prepaid Expenses (Details Textual) HTML 20K
28: R46 Construction in Progress (Details Textual) HTML 39K
69: R47 Property, Plant and Equipment (Details) HTML 33K
23: R48 Property, Plant and Equipment (Details Textual) HTML 28K
31: R49 Intangible Assets (Details) HTML 28K
46: R50 Intangible Assets (Details Textual) HTML 24K
53: R51 Related Party Debt (Details Textual) HTML 23K
68: R52 Income Tax and Taxes Payable (Details) HTML 35K
16: R53 Income Tax and Taxes Payable (Details 1) HTML 34K
57: R54 Income Tax and Taxes Payable (Details 2) HTML 46K
43: R55 Income Tax and Taxes Payable (Details Textual) HTML 26K
21: R56 Earnings Per Share (Details) HTML 40K
24: R57 Commitments and Contingencies (Details) HTML 34K
51: R58 Commitments and Contingencies (Details Textual) HTML 30K
71: R59 Major Suppliers and Customers (Details Textual) HTML 37K
45: XML IDEA XML File -- Filing Summary XML 106K
17: EXCEL IDEA Workbook of Financial Reports XLSX 160K
44: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.27M
9: EX-101.INS XBRL Instance -- chhe-20130630 XML 2.06M
11: EX-101.CAL XBRL Calculations -- chhe-20130630_cal XML 103K
12: EX-101.DEF XBRL Definitions -- chhe-20130630_def XML 535K
13: EX-101.LAB XBRL Labels -- chhe-20130630_lab XML 661K
14: EX-101.PRE XBRL Presentations -- chhe-20130630_pre XML 657K
10: EX-101.SCH XBRL Schema -- chhe-20130630 XSD 166K
67: ZIP XBRL Zipped Folder -- 0001144204-13-055291-xbrl Zip 174K
Agreement No.:
Health Food Technology Transfer Agreement
Project Name: The transfer of the twelve health food approval numbers of Health Foods, including Dr. Xiao Brand Honeysuckle Pearl Capsule, Dr. Xiao Brand Multivitamin Tablet, Dr. Xiao Brand Zhengdian Capsule, Dr. Xiao Brand Shengui Capsule, Dr. Xiao Brand Multivitamin Tablet (Woman), Dr. Xiao Brand Shikong Soft Capsule, Dr. Xiao Brand Huangjingdanggui Tablet, Dr. Xiao Brand Xingxing Soft Capsule, Dr. Xiao Brand Vitamin A Fish Oil Soft Capsule, Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule and LB Brand Xinpin Capsule, and the trademark ownership of Dr. Xiao’s No.5 and No.30 category product and LB’s No.30 category product.
Transferee (Party A): Harbin Humankind Biology Technology Co., Limited
Transferor (Party B): Guangzhou Aoda Biology Beauty Healthy Technology Co., Ltd
| Signed on January 18, 2013 |
| Signed in Harbin |
Printed and made by Ministry of Science and Technology of PRC
C:
| C: 1 |
Instruction
I This agreement is a sample printed and made by Ministry of Science and Technology of PRC. Technology agreement registration administration may recommend this sample to the parties entering into Technology agreement.
II This agreement is applicable to the agreement where transferor provides knowhow to transferee, specify its usage rights and transfer rights between the parties, and the usage fees to be paid by transferee.
III If there are more than one parties on one side of agreement, they shall be listed as “common transfee” or “common transferer”, respectively, under the category of “Principal” and “Agent” (in the added pages), based on their roles in this Agreement.
IV For the items not covered in this Agreement, the parties of the agreement may specify in supplementary pages, which shall be the integral part of this Agreement.
V The parties who adopt this sample agreement shall fill in “none” for those terms that they agreed not to fill in.
C:
| 2 |
Health Food Technology Transfer Agreement
| Transferee (Party A): Harbin Humankind Biology Technology Co., Limited | |
| Location: No. 168 Binbei St. Songbei District. Harbin | |
| Legal Representative: Kai Sun | |
| Contact: Zhiqiang Wang | |
| Contact Method: | |
| Mail address: No. 168 Binbei St. Songbei District Harbin | |
| Tel.: | Fax: |
| E-mail: | |
| Transferor (Party B): Guangzhou Aoda Biology Beauty Healthy Technology Co., Ltd | |
| Location: 43/F Weiduoli Plaza Tiyuxi Road Tianhe District Guangzhou City | |
| Legal Representative: Hui Wu | |
| Contact: Juan Wu | |
| Contact Method: | |
| Mail address: 43/F Weiduoli Plaza Tiyuxi Road Tianhe District Guangzhou City | |
| Tel.: | Fax: |
| E-mail: | |
Party B will transfer to Party A the approval numbers and knowhow of twelve health foods, including formula, manufacturing process, quality standard and product registration approval certificates, as well as the trademarks of Dr. Xiao of No.5 and No.30 category and LB of No.30 category, and Party A shall pay the consideration to acquire them. The twelve health foods refer to Health Food including Dr. Xiao Brand Honeysuckle Pearl Capsule(Approval No. Guoshijianzi G20100656), Dr. Xiao Brand Multivitamin Tablet(Approval No. Guoshijianzi G20080176), Dr. Xiao Brand Zhengdian Capsule(Approval No. Guoshijianzi G20070261), Dr. Xiao Brand Shengui Capsule(Approval No. Guoshijianzi G20080297), Dr. Xiao Brand Multivitamin Tablet (Woman) (Approval No. Guoshijianzi G20070338), Dr. Xiao Brand Shikong Soft Capsule(Approval No. Guoshijianzi G20080096), Dr. Xiao Brand Huangjingdanggui Tablet(Approval No. Guoshijianzi G20080201), Dr. Xiao Brand Xingxing Soft Capsule(Approval No. Guoshijianzi G20080080), Dr. Xiao Brand Vitamin A Fish Oil Soft Capsule(Approval No. Guoshijianzi G20080406), Dr. Xiao Brand Colon Cleanser Granules(Approval No. Guoshijianzi G20060061), Dr. Xiao Brand Jianli Soft Capsule(Approval No. Guoshijianzi G20050710), and LB Brand Xinpin Capsule(Approval No. Guoshijianzi G20050770). Based on friendly discussion and good faith negotiation, contract law of PRC and related laws, both parties come into the following terms.
C:
| 3 |
Article I The transferred technologysecrets (knowhow) includes:
| 1. | Scope of technology secrets: formula, production process and quality criterion etc. |
| 2. | Technology index and parameter: refer to transferred technology documents. |
Article II In order to guarantee Party A to apply the technology secrets efficiently, Party B shall provide the following technology documents to Party A:
| 1. | technology documents used for the government approval; |
| 2. | original approval certificate and attachments; |
| 3. | other requirements under Requirements about Health Food Registration Application (Trial) |
Article III Time, place and method to deliver technology documents by Party B
| 1. | Time: on the time when Party B received full payment from Party A; |
| 2. | Place: Harbin or by express mail; |
| 3. | Method: both parties inspect and sign on the transfer record. |
Article IV Transfer fee and payment method for transfer approval numbers, technology secrets and trademarks:
| 1. | Total transfer fees is RMB 30,000,000 including tax fees, trademarks etc. |
C:
| 4 |
| 2. | After the Agreement is effective, Party A shall pay down payment of RMB 4,500,000 to Guangzhou Aoda Biology Beauty Healthy Technology Co., Ltd. After received the down payment, Party B shall provide technology documents for production, including formula, manufacturing process, enterprise standard and original trademark certificates etc. |
| 3. | When Party A completed production of three batches of samples, and filed and confirmed with Heilongjiang Food and Drug Administration that the transfer may proceed, Party A shall pay the remaining RMB 25,500,000 to Guangzhou Aoda Biology Beauty Healthy Technology Co., Ltd. Party B shall provide Party A all the technology documents, original approval certificates and trademarks registration certificates. |
Article V Party B’s work about executing or transferring the project technology secrets before the Agreement is effective.
Party B’s work about executing the project technology secrets (time, place, method and scale):
The technology secrets were formed based on small scale trial and middle scale trial during the R&D stage. Party B never enters into the commercialized production of the technology products.
Article VI In order to guarantee Party A to execute the project knowhow efficiently, Party B shall provide the following technology service and technology guidance.
| 1. | The content of technology service and guidance. Party B shall direct and assist Party A to complete qualified products of three batches, and provide consulting and guidance service for registration application of the technology transfer product. |
| 2. | The method of technology service and guidance: via phone call or mail, or appoint the staff to provide on-site guidance service. |
Article VII Related documents provide by Party B based on Detailed Requirements on Registration Application of Technology Transfer Products.
C:
| 5 |
| 1. | Technology documents provided on the transfer of the twelve products |
| (i) | Certificates: obtain Health Food Approval Certificates issued by China Food and Drug Administration (CFDA). |
| (ii) | Technology contents, including product R&D report; formula and the basis, usage basis for raw material and accessory material, the content and inspection method of efficacy ingredient or indicative ingredient, flow chart of production processing as well as the detailed explanation and related research documents; quality criterion(for company) and explanation including quality criterion of raw material and accessory material; category, name, quality criterion and basis to choose of package material with direct contact with product; testing report provided by inspection institution and the related documents including toxicology security evaluation report, health efficacy evaluation report including animal test and human trail eating test, efficacy ingredients identification report, stability testing report, and hygienic testing report, product tag, product description sample, other documents to assist product inspection, and the related work to this project including on-site inspection on sample testing, selective examination of sample product and check etc. |
| 2. | Original Approval Certificate. Obtain Health Food Approval Certificate issued by China Food and Drug Administration (CFDA). |
| 3. | Other documents need to be provided by Party B based on the regulation of the sixth article of Requirements about Health Food Registration Application (trial), Detailed Requirements on Registration Application of Technology Transfer Products. |
Article VIII Other issues related to this Agreement specified by both parties:
| 1. | This Agreement is entered into based on Health Food Registration Administration (trial). Both parties shall conform with the qualifications specified in this regulations. Party B promises to provide the legal documents and legal procedures for the registration application of the technology transfer product, but will not assume any responsibilities for the result of the application. Party A shall be responsible for product transfer procedures and pay for the related fees such as inspection and notary, etc. |
C:
| 6 |
| 2. | Transfer period is not closed until all transfer procedures are completed and commences from the date which is mutually confirmed by both parties. |
| 3. | Based on the related regulations in the Administration, Party B promises it did not and will not manufacture and sell the products. Party B shall transfer the technology documents to Party A when Party A has paid off the consideration. Party A shall complete the sample production and all preparation work within two months and provide to local Food and Drug Administration for transfer application. Party B shall fulfill the obligations including provide seal service and related service. |
| 4. | During the period when this Agreement is executed, Party B is prohibited to transfer the contract object to the third party. If Party B breaches, it shall compensate RMB 5,000,000 to Party A in addition to refunding the money Party B has been paid. |
| 5. | If Party A could not pay for the consideration15 days beyond the deadline of this Agreement, Party A is considered to waive the transfer. Party B has the rights to terminate the Agreement anytime and pays back to Party A the money paid to terminate the Agreement. |
| 6. | If the transfer fails because of Party B, within one week after CFDA declines to approve or within seven days after Party A inform to terminate the Agreement, or both parties negotiate to fix transfer date and sign supplementary agreement, Party B shall pay back all money paid by Party A and the Agreement is terminated. If part of products could not be transferred, Party B shall pay back the money at RMB 2,500,000 each product which is not transferred. |
| 7. | If the Agreement is not executed because of Party A, Party A has the rights to appoint the third party as transferee to fulfill the Agreement and Party B shall continue to cooperate to conduct transfer procedures. |
C:
| 7 |
| 8. | If the Agreement could not be executed because of force majeure, both parties will not ask for compensation for each other include but not limited to the terms and documents which have been performed. |
| 9. | During the period when the Agreement is executed, if the legal entity of both parties occurs dissolution, rescind and changes etc., one party shall inform the other party by written notice. Both parties shall specify otherwise or negotiate to solve the problem about legal entity of rights and obligations. |
| 10. | During the transfer period, Party B shall permit Party A to manufacture and sell in the name of Party B and cooperate with Party A. If Party B does not cooperate, it shall compensate RMB 5,000,000 to Party A. In the process of sell in the name of Party B, if Party A breaches national sales regulation and causes damages to Party B’s fame, Party A shall compensate the economic loss caused to Party B. |
| 11. | Because Party B needs the fund urgently, both parties agree to modify the article four of way of payment based on mutual negotiation. Party A shall pay transfer fees of RMB 30,000,000 at one time to Party B within three business days after the Agreement is signed and notarized, provided that Party B shall provide contract guarantee of ownership of all Baidaifu trademarks and manufacture qualification under the name of Guangzhou Aoda Biology Beauty Healthy Technology Co., Ltd. The contact guarantee shall be released if Party A completes sample production of three batches and make the application to Heilongjiang Food and Drug Administration which confirms the transfer could be accepted. |
| 12. | If Party A has paid off the consideration, but Party B could not cooperate with Party A to complete the transfer, Party B shall double compensate Party A. including all related fees occurred during transfer period. In order to guarantee the economic benefit of both parties, Party B shall provide all transfer documents within seven days after the Agreement is signed. Within two business days after inspection and confirmation by authorized person from Party A, Party A will shall transfer the money to the bank account of Party B. Concurrent with wire payment, Party B shall provide all documents to Party A. |
| 13. | Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule, and LB Brand Xinpin Capsule are at re-registration stage and are not possible for transfer at the stage. The three products also involve in new standard approval regarding to future re-registration of health foods. Because the transfer involves potential risk, both parties come into the following terms after friendly negotiation: |
C:
| 8 |
(i) Party B shall assume the related feesfor registration of Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule, and LB Brand Xinpin Capsule. , Failure to do so will be deemed as breach of contract.
(ii) With respect to all documents related to re-registration, Party B shall provide and submit them to Authorities for approval on time to guarantee the approval of Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule, and LB Brand Xinpin Capsule. Failure to do that will be deemed as default and Party B shall assume the liablities.
(iii) Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule, and LB Brand Xinpin Capsule is not available for transfer at this stage. After complete the re-registration of the three products, Party B shall transfer to Party A Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule, and LB Brand Xinpin Capsule in time.
(iv) If Party B makes efforts to cooperate the re-registration of Dr. Xiao Brand Colon Cleanser Granules, Dr. Xiao Brand Jianli Soft Capsule, and LB Brand Xinpin Capsule, yet fails to transfer the three technologies to Party A, Party B shall pay back the transfer fees at RMB 2,500,000 for each product within seven business days.
Article IX The Agreement is exclusive. If Party B breaches, it shall pay RMB 1,000,000 to Party A as breaching compensation.
Article X For any disputes arise from executing this Agreement, both parties shall negotiate to settle the disputes. If the disputes are not settled by negotiation, either party may bring the lawsuit in the court where the plantiff resides.
C:
| 9 |
Article XI As for the items not covered in this Agreement, both parties need to sign supplementary agreement which has the same legal effect with this Agreement.
Article XII This Agreement is executed in six copies. Party A and Party B held three copies respectively.
This Agreement is taken into effect after the authorized representatives of both parties sign, seal and notarize the Agreement.
Party A: Harbin Humankind Biology Technology Co., Limited
Authorized representative: /s/Zhiqiang Wang
Signed on January 18, 2013
Party B: Guangzhou Aoda Biology Beauty Healthy Technology Co., Ltd
Authorized representative: /s/Juan Wu
Signed on January 18, 2013
C:
| 10 |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/15/13 | |||
| For Period end: | 6/30/13 | NT 10-K | ||
| 1/18/13 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/13/23 China Health Inds Holdings, Inc. 10-K 6/30/23 72:5M EdgarAgents LLC/FA 4/10/23 China Health Inds Holdings, Inc. 10-K/A 6/30/22 69:4.7M EdgarAgents LLC/FA 2/24/23 China Health Inds Holdings, Inc. 10-K/A 6/30/22 69:4.7M EdgarAgents LLC/FA 9/15/22 China Health Inds Holdings, Inc. 10-K 6/30/22 71:4.7M EdgarAgents LLC/FA 9/20/21 China Health Inds Holdings, Inc. 10-K 6/30/21 69:4.4M EdgarAgents LLC/FA 10/13/20 China Health Inds Holdings, Inc. 10-K 6/30/20 68:3.6M EdgarAgents LLC/FA |